AKT1 and prostate carcinoma: Afrocyclamin A inhibits the phosphorylation of PI3K, Akt, and mTOR in prostate cancer DU-145 cells, induces autophagic vacuole formation, and suppresses cancer cell migration and invasion in a dose-dependent manner [39].